Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
03.08.26
/
50%
€146.25
Target price
03.08.27
€182.15
Performance (%)
-0.96%
Price
17:07
€144.85
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 03.08.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -0.96% |
| iShares Core DAX® | 2.334% |
| iShares Nasdaq 100 | 1.370% |
| iShares Nikkei 225® | 2.437% |
| iShares S&P 500 | 1.259% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Canaccord Genuity Group Inc. from $200.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.90
07.04.26
07.04.26
€173.46
07.04.27
07.04.27
28.30%
17:07
17:07
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€89.90
30.03.23
30.03.23
€120.95
30.03.24
30.03.24
47.22%
01.04.24
01.04.24